CWM
CLB icon

Cornerstone Wealth Management’s Core Laboratories CLB Stock Holding History

Cornerstone Wealth Management’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-11,687
Closed -$122K – 471
2018
Q3 		$122K Buy
+11,687
New +$1.32M ﹤0.01% 1260

Other funds holding CLB

WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

Cornerstone Wealth Management's CLB Position: Q4 2018 in Review

Cornerstone Wealth Management sold out of Core Laboratories (CLB) in Q4 2018, closing a stake of 11,687 shares — an estimated $122K sold.

Cornerstone Wealth Management first reported a position in CLB in Q3 2018 and held it in 1 quarter. The position peaked at $122K in Q3 2018. 320 funds tracked by Wall St. Rank hold CLB as of Q4 2018.

  • Cornerstone Wealth Management reported no remaining Core Laboratories position as of Q4 2018 after selling out during the quarter.
  • Cornerstone Wealth Management sold 11,687 Core Laboratories shares in Q4 2018, an estimated $122K.
  • Cornerstone Wealth Management first reported a position in Core Laboratories in Q3 2018 and held it in 1 quarter.
  • Cornerstone Wealth Management's Core Laboratories position peaked at $122K in Q3 2018.
  • 320 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2018.

Based on Cornerstone Wealth Management's 13F filing for Q4 2018, filed 13 Feb 2019.